Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 5/20 | 1.00 |
| ▸ | CCR8 | P51685 | 5/20 | 1.00 |
| ▸ | LMNA | P02545 | 4/20 | 1.00 |
| ▸ | CCR5 | P51681 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | HTT | P42858 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | GMNN | O75496 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MMP9 | P14780 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | NFKB1 | P19838 | 1/20 | 1.00 |
| ▸ | MMP8 | P22894 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenanthroline SCHEMBL8845760 | 1.00 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL29354015 | 1.00 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL8312 | 1.00 | CCR1 (1.00) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21060516 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL22462277 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL22982126 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21300488 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL21044608 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL3790396 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E | |
| Phenanthroline SCHEMBL345410 | 0.97 | CCR1 (0.94) | CCR1CCR8LMNACCR5KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 373 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122025517-A | Manufacturing method of stable traditional internal liquid filling lithium electrode | 桂林优利特医疗电子有限公司 | 2026-05-12 | — | — | CN | claimed |
| CN-121085908-B | Aromatic amine compound, mixture, organic light-emitting device, and display panel | 广州华睿光电材料有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-20260098072-A1 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO INC (US) | 2026-04-09 | — | — | US | claimed |
| EP-4605407-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | Endevica Bio, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| CN-120121604-A | Rapid detection method for food safety | 云南商测质量检验技术服务有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-3720468-B1 | TISSUE REPAIR | UNIV SUSSEX (GB) | 2024-10-30 | — | — | EP | claimed |
| CN-118831629-A | Preparation method and application of Fe-N co-coordination doped porous carbon catalyst | 南华大学 | 2024-10-25 | — | — | CN | claimed |
| WO-2024086381-A2 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | ENDEVICA BIO, INC. (US) | 2024-04-25 | — | — | WO | claimed |
| CN-110041351-B | Er (III) luminescent material containing phenanthroline, modified imidazole carboxylic acid and pyridine carboxylic acid mixed ligand and preparation method thereof | 洛阳师范学院 | 2024-04-05 | — | — | CN | claimed |
| EP-3509993-B1 | CALCIUM CARBONATE-CONTAINING COMPOSITE POWDER WITH MICROSTRUCTURED PARTICLES WITH INHIBITING CALCIUM CARBONATE | SCHAEFER KALK GMBH & CO KG (DE) | 2024-03-06 | — | — | EP | claimed |
| CN-114342133-A | Redox flow battery | 新加坡国立大学 | 2022-04-12 | — | — | CN | claimed |
| EP-4746862-A2 | ENHANCED DELIVERY EPINEPHRINE AND PRODRUG COMPOSITIONS | Aquestive Therapeutics, Inc. (US) | 2026-05-27 | — | — | EP | disclosed |
| CN-122036764-A | O-phenanthroline-based double BODIPY fluorescent dye with asymmetric structure, and preparation method and application thereof | 齐鲁医药学院 | 2026-05-15 | — | — | CN | disclosed |
| CN-122036764-A | O-phenanthroline-based double BODIPY fluorescent dye with asymmetric structure, and preparation method and application thereof | 齐鲁医药学院 | 2026-05-15 | — | — | CN | disclosed |
| CN-122029280-A | Oligonucleotide with glycol modification | 马萨诸塞大学 | 2026-05-12 | — | — | CN | disclosed |
| US-20220072618-A1 | LOW-TEMPERATURE CASE HARDENING OF ADDITIVE MANUFACTURED ARTICLES AND MATERIALS AND TARGETED APPLICATION OF SURFACE MODIFICATION | SWAGELOK COMPANY | 2022-03-10 | — | — | US | disclosed |
| EP-3475367-B1 | PRODUCTION OF CRYSTALLINE CARBON STRUCTURE NETWORKS | CARBONX IP 3 B V (NL) | 2022-03-09 | — | — | EP | disclosed |
| EP-3956338-A1 | METAL COMPLEXES | Merck Patent GmbH (DE) | 2022-02-23 | — | — | EP | disclosed |
| WO-2022031591-A2 | OLIGONUCLEOTIDES FOR HTT-1A MODULATION | UNIVERSITY OF MASSACHUSETTS (US) | 2022-02-10 | — | — | WO | disclosed |
| CN-109536422-B | Aerobic high-density culture method of lactic acid bacteria | 广西大学 | 2022-02-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098072-A1 | METHODS OF STIMULATING APPETITE AND/OR INCREASING BODY WEIGHT USING NON-NATURALLY OCCURRING MELANOCORTIN RECEPTOR ANTAGONIST ANALOGS | MC1R, MC4R, MC5R | CCR1 2214/4885CCR8 1955/4885LMNA 4427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.